Trial intelligence / Profile preview

Tobramycin serum concentrations during SDD in ICU patients

NL-OMON24557Active, not recruiting

Sponsor
Martini Ziekenhuis
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of tobramycin in Healthcare-associated infection (HAI), hospital-acquired pneumonia (HAP) and candidemia, sponsored by Martini Ziekenhuis. Started Mar 2016; status: active, not recruiting.

02

Drugs

tobramycin
03

Conditions

Healthcare-associated infection (HAI)hospital-acquired pneumonia (HAP)candidemia

Beyond the preview

Go deeper on NL-OMON24557.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON24557.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call